SARS-CoV-2 Envelope Protein Polyclonal antibody

SARS-CoV-2 Envelope Protein Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

virus and More (1)

Applications

IF, ELISA

Conjugate

Unconjugated

Cat no : 28904-1-AP

Synonyms

COV19, COV-19, COVID19, COVID-19 E protein, E Protein, envelope protein, SARS-COV-2 E Protein, SARS-CoV-2 Envelope Protein



Tested Applications

Positive ELISA detected inRecombinant protein

Recommended dilution

ApplicationDilution
Enzyme-linked Immunosorbent Assay (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

IFSee 1 publications below

Product Information

28904-1-AP targets SARS-CoV-2 Envelope Protein in IF, ELISA applications and shows reactivity with virus samples.

Tested Reactivity virus
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SARS-CoV-2 Envelope Protein fusion protein Ag30690
Full Name COVID-19 E Protein
GenBank Accession NumberNC_045512
Gene Symbol SARS-CoV-2 Envelope Protein
Gene ID (NCBI) 43740570
RRIDAB_2881232
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).

Publications

SpeciesApplicationTitle
humanIF

Front Cell Neurosci

The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model

Authors - Jiahang Ju